Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis
Current Drug Target -Cardiovascular & Hematological Disorders · 2001
DOI: 10.2174/1568006013337944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Cardiovascular & Hematological Disorders, 2001. Verfasst von L Bocksch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Group, John P. Robarts Research Institute, London, Ontario, Canada. Die Arbeit wurde bisher 26-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vascular Biology Group, John P. Robarts Research Institute, London, Ontario, Canada.
Zitieren
APA
Bocksch, L., Stephens, T., Lucas, A., & Singh, B. (2001). Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis. Current Drug Target -Cardiovascular & Hematological Disorders. https://doi.org/10.2174/1568006013337944
Vancouver
Bocksch L, Stephens T, Lucas A, Singh B. Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis. Current Drug Target -Cardiovascular & Hematological Disorders. 2001. doi:10.2174/1568006013337944
BibTeX
@article{Bocksch2001,
author = {Bocksch, L and Stephens, T and Lucas, A and Singh, B},
title = {Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis},
journal = {Current Drug Target -Cardiovascular & Hematological Disorders},
year = {2001},
doi = {10.2174/1568006013337944}
}
EUVIMED